The Diabetes Market Outlook to 2016

Date: May 22, 2011
Pages: 132
Price:
US$ 3,835.00
Publisher: Business Insights
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: D1AED4E6ADDEN
Leaflet:

Download PDF Leaflet

The Diabetes Market Outlook to 2016
Price
Global License: US$ 14,780.00


Introduction

This report provides comprehensive coverage of the diabetes market, incorporating a disease overview and detailed epidemiological analyses of the therapy area. It makes a wide-ranging assessment of the marketed product portfolio, R&D pipeline, market-share data, sales forecasts and competitive landscape of the major players. The market size is forecast to 2016.

Features and benefits
  • Quantify and assess the patient potential and treatment trends of diabetes globally.
  • Understand how recent events are affecting the performance of major products, and how their marketers are confronting competitive challenges.
  • Benchmark the leading anti-diabetic pipeline products under development and evaluate the evolution of the market in the forecast period.
  • Identify the leading players in the diabetes market and analyze their marketed portfolios, R&D pipelines and market strategies.
  • Evaluate the key market trends and growth strategies that holds potential for shaping the future diabetes market.
Highlights

Diabetes is the fifth leading cause of death in the developed countries. Diabetes prevalence is increasing at a fast pace in the developing countries due to lifestyle changes and a lack of awareness of its causes. This presents a huge opportunity to the marketers of diabetes products.

The diabetes landscape is dynamic, with active R&D leading to the development of newer drug classes such as incretin mimetics, and regulatory agencies such as the FDA having increased the regulatory surveillance over diabetes drugs to avoid any “unacceptable” cardiovascular risk.

Stringent regulatory screening in the light of increasing reports of serious adverse events of cardiovascular risk factors has had repercussions in terms of product withdrawal and has also delayed the launch of several late stage development products.

Your key questions answered
  • What are the new therapy approaches in anti-diabetes market and which of these offer significant potential in the future?
  • What is the forecast commercial potential of the most promising compounds in clinical development?
  • Which products have been the major revenue generators in the market and what other categories are forecast to have commercial potential through 2016?
  • What are the current growth drivers in the global diabetes market shaping the future?
  • How will the patient population of diabetes sufferers change between 2010 and 2016?
Executive Summary
  Overview and patient potential of diabetes
  Global market analysis
  Pipeline analysis
  Competitive landscape
About the author
  Disclaimer
Overview and patient potential of diabetes
  Summary
  Introduction
  What is diabetes?
  Types of diabetes
    Type 2 diabetes
    Gestational diabetes mellitus
  Impaired glucose tolerance
  Diabetic complications
  Epidemiology
  Diagnosis
  How is diabetes measured?
  Treatment algorithm
Global market analysis
  Summary
  Introduction
  Market analysis by country
    India
    China
  Key events/trends in the diabetes market
    Bydureon approved in the EU
    Eli Lilly and Boehringer Ingelheim’s collaborates over diabetes drug
    Novo Nordisk receives subpoena for three marketed products
    Newer agents recommended by NICE for diabetes treatment
    Amylin sues Lilly
  Market analysis by drug class
    Diabetes drug classes
    The insulin landscape
    Drugs targeting underlying causes of diabetes
    DPP-IV and GLP-1 differences
  Therapy area sales forecast
  Leading brands of the diabetes market
  Leading brands sales forecast
Pipeline analysis
  Summary
  Introduction
  Emerging trends/key events in diabetes R&D
    Unmet need
    Inhaled insulin still a distant reality
    New approaches in diabetes R&D: magnesium, chromium, and vanadium
    Regulatory changes in the light of increasing cardiovascular adverse effects
  Profiles of key pipeline products
    Profiles of key molecules
  Pipeline sales forecast
Competitive Landscape
  Summary
  Introduction
  Detailed analysis of the diabetes market players
    Novo Nordisk
    Sanofi
    Takeda
    Eli Lilly
    Merck & Co.
Appendix
  Scope
  Market forecast
  Epidemiology forecast
  Glossary/Abbreviations
  Bibliography/References
Skip to top


Ask Your Question

The Diabetes Market Outlook to 2016
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: